帕金森病突触前末梢完整性与葡萄糖代谢相关
研究纳入16例帕金森病患者和11例年龄匹配健康对照,用[18F]SynVesT-1、FDG及[18F]FP-CIT PET评估突触密度、葡萄糖代谢与多巴胺转运体。帕金森病组尾状核突触密度显著低于对照组(SUVR 2.51±0.36 vs 3.18±0.32,p<0.001),尾状核后连合部突触密度降低与DAT及葡萄糖代谢显著相关,且突触密度部分中介葡萄糖代谢与DAT可用性的关系。
要点
- 帕金森病组尾状核[18F]SynVesT-1 SUVR低于对照组(2.51±0.36 vs 3.18±0.32,p<0.001)
- 尾状核后连合部突触密度与DAT(r=0.61,p<0.001)及葡萄糖代谢(r=0.73,p<0.001)显著相关
- 尾状核后连合部突触密度部分中介葡萄糖代谢与DAT可用性的关系(间接效应β4=0.039,p=0.024)
核心结论
- [18F]SynVesT-1特异性结合SV2A反映突触密度,[18F]SynVesT-1与[18F]FDG所反映的变化存在正相关代谢模式。
研究设计与样本
- 研究纳入16例帕金森病患者和11例年龄匹配健康对照,均接受[18F]SynVesT-1和FDG PET,帕金森病患者另接受[18F]FP-CIT PET。
- 在所选感兴趣区内比较帕金森病组与年龄匹配正常对照的突触密度差异,并评估[18F]SynVesT-1 SUVR与[18F]FP-CIT SUVR及[18F]FDG SUVR的相关性。
主要发现
- 帕金森病组尾状核突触密度显著低于对照组(SUVR:2.51±0.36 vs 3.18±0.32,p<0.001)。
- 帕金森病组尾状核前连合部SUVR为2.42±0.29 vs 对照组2.63±0.32(p<0.01),尾状核后连合部为0.76±0.31 vs 0.97±0.33(p<0.001)。
- 尾状核后连合部突触密度降低与DAT(r=0.61,p<0.001)及葡萄糖代谢(r=0.73,p<0.001)显著相关。
- 尾状核后连合部突触密度对葡萄糖代谢与DAT可用性的关系存在部分中介效应(间接效应:β4=0.039,p=0.024)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the relationship of synaptic loss with glucose metabolism and dopaminergic transporters in Parkinson's disease (PD) patients. METHODS: A total of 16 patients with PD and 11 age-matched healthy controls underwent positron emission tomography (PET) with the tracers [18F]SynVesT-1, a ligand for the presynaptic terminal marker synaptic vesicle protein 2 A (SV2A), and FDG. PD patients also underwent PET with the dopamine transporter (DAT) ligand [18F]FP-CIT. The difference in synaptic density between PD patients and age-matched normal controls(NCs) was determined in the selected regions of interest, and the correlations of the [18F]SynVesT-1 PET SUVRs with [18F]FP-CIT PET SUVRs and [18F]FDG PET SUVRs were evaluated. RESULTS: Compared with that in the NC group, the synaptic density in the caudate region was significantly lower in the PD group (SUVR: 2.51 ± 0.36 vs. 3.18 ± 0.32, p < 0.001), especially in the pre-commissural caudate and post-commissural caudate (SUVR: 2.42 ± 0.29 vs. 2.63 ± 0.32, p < 0.01; 0.76 ± 0.31 vs. 0.97 ± 0.33, p < 0.001). A reduced synaptic density was significantly correlated with DAT (r = 0.61, p < 0.001) and glucose metabolism (r = 0.73, p < 0.001) in the post-commissural caudate. In the post-commissural regions of the caudate, there was a partial mediating effect of synaptic density on the relationship between glucose metabolism and DAT availability (indirect effect: β4 = 0.039, p = 0.024). CONCLUSION: [18F]SynVesT-1 binds specifically to SV2A, reflecting synaptic density, and there is a positive correlation metabolic pattern related to the changes reflected by [18F]SynVesT-1 and [18F]FDG.
引用
- Wang W, Wang Y, Xu L, et al. Presynaptic terminal integrity is associated with glucose metabolism in Parkinson's disease. Eur J Nucl Med Mol Imaging. 2024. PMID: 39572432. doi:10.1007/s00259-024-06993-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。